New implant as remedy for glaucoma
Glaucoma is a serious eye disease that affects three to five percent of the population over the age of 50, and is a condition that not infrequently results in blindness. The condition usually indicates that the eye pressure is (significantly) elevated. Eye drops and laser treatments usually work well, but surgical treatment is often indicated to get eye pressure permanently under control.
In severe cases, the insertion of a plastic implant is necessary. Although these implants often work well, a great deal of knowledge and skill is required for correct placement and intensive patient follow-up is a must; the risk of possible complications is fairly high and it can be difficult to predict the eye-pressure-lowering effect. This unpredictability and fear of complications means there is a great need for safe and standardized minimally invasive surgery, making it a more acceptable alternative for both surgeons and patients. In order to meet this need, a new and promising glaucoma implant has been developed under the leadership of the Maastricht UMC+ University Clinic for Ophthalmology and researchers at the Technical University of Eindhoven. The challenge for startup PEYEONEER MedTech, based at the Brightlands Maastricht Health Campus, is to get the glaucoma implant to patients.
Read the full article on the Brightlands website.
Also read
-
Mimic the true nature of tissues by building complex in vitro models
Paul Wieringa (MERLN) works on innovative models to study endometriosis and the fallopian tube.
-
Vacancy: Farm-to-table Chef-designer-researcher
The Research, Education and Action Lab into Collective and Circular Transformation (REACCT) is looking for an experienced chef with a strong interest in research, farm-to-table experimental practices, and building design (two year part-time position).
-
BRAINS Consortium Awards Two New Research Projects
The BRAINS consortium has awarded two new research projects, bringing the total number to five.
